Literature DB >> 18373386

The effect of chronic doxorubicin treatment on mitogen-activated protein kinases and heat stress proteins in rat hearts.

P Šimončíková1, T Ravingerová, M Barančík.   

Abstract

The study has been designed to characterize protein systems involved in the responses of rat hearts to chronic doxorubicin (DOX) treatment. We investigated the influence of DOX on cardiac function, mitogen-activated protein kinases (MAPKs) and heat stress proteins (HSPs). Doxorubicin was administered to rats by intraperitoneal injections over a period of 6 weeks. In control and DOX-treated hearts exposed to 20 min global ischemia and 40 min reperfusion the recovery of contractile function after ischemia/reperfusion (I/R) was determined. The levels and phosphorylation state of proteins in tissue samples were analyzed using specific antibodies. We found an activation of extracellular signal-regulated kinases (ERKs) in rat hearts exposed to DOX treatment and better recovery of contractile function after I/R. Analysis of HSPs showed that DOX induced up-regulation of the levels of HSP60 and down-regulation of HSP70 levels. The levels and/or specific phosphorylation of other studied proteins (p38-MAPK, HSP27, HSP90) were not influenced by DOX. The results point to the possible role of ERKs and some HSPs in mechanisms underlying the response of rat hearts to chronic DOX treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373386     DOI: 10.33549/physiolres.931558

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

1.  Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats.

Authors:  Monika Ivanová; Ima Dovinová; Ludmila Okruhlicová; Narcisa Tribulová; Petra Simončíková; Monika Barteková; Jana Vlkovičová; Miroslav Barančík
Journal:  Acta Pharmacol Sin       Date:  2012-03-26       Impact factor: 6.150

2.  Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice.

Authors:  Kaushik Vedam; Yoshinori Nishijima; Lawrence J Druhan; Mahmood Khan; Nicanor I Moldovan; Jay L Zweier; Govindasamy Ilangovan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

3.  Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.

Authors:  Katerina Naka K; Patra Vezyraki; Alexandros Kalaitzakis; Stelios Zerikiotis; Lampros Michalis; Charalampos Angelidis
Journal:  Cell Stress Chaperones       Date:  2014-04-20       Impact factor: 3.667

4.  All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway.

Authors:  Liang Yang; Cheng Luo; Cong Chen; Xun Wang; Wen Shi; Jiankang Liu
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

5.  Skeletal Muscle for Endomyocardial Biopsy: Comparable Stress Response in Doxorubicin Cardio-myopathy.

Authors:  Rosa Maita; Mirian Strauss; Guillermo Anselmi
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

6.  RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.

Authors:  Tarek Magdy; Zhengxin Jiang; Mariam Jouni; Hananeh Fonoudi; Davi Lyra-Leite; Gwanghyun Jung; Marisol Romero-Tejeda; Hui-Hsuan Kuo; K Ashley Fetterman; Mennat Gharib; Brian T Burmeister; Mingming Zhao; Yadav Sapkota; Colin J Ross; Bruce C Carleton; Daniel Bernstein; Paul W Burridge
Journal:  Cell Stem Cell       Date:  2021-09-15       Impact factor: 24.633

7.  Quercetin improves postischemic recovery of heart function in doxorubicin-treated rats and prevents doxorubicin-induced matrix metalloproteinase-2 activation and apoptosis induction.

Authors:  Monika Barteková; Petra Šimončíková; Mária Fogarassyová; Monika Ivanová; Ľudmila Okruhlicová; Narcisa Tribulová; Ima Dovinová; Miroslav Barančík
Journal:  Int J Mol Sci       Date:  2015-04-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.